1 / 7

Molecular Diagnostics Market by Technology & Application - 2020 | MarketsandMarkets

The molecular diagnostics market is expected to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. High prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system are driving the growth of the market.

Download Presentation

Molecular Diagnostics Market by Technology & Application - 2020 | MarketsandMarkets

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MarketsandMarkets Presents Molecular Diagnostics Market worth 9,333.8 Million USD by 2020 http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

  2. The molecular diagnostics market is expected to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020. High prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system are driving the growth of the market. • The major technologies studied in the report include PCR, INAAT, microarrays, hybridization, DNA sequencing and next generation sequencing (NGS), and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate. • Early buyers will receive 10% customization on reports. http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

  3. The molecular diagnostics market, by application, is categorized into infectious diseases, oncology, genetics, blood screening, microbiology, and others (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2015, followed by the blood screening and oncology segments. • On the basis of products and services, the molecular diagnostics market is segmented into instruments, reagents, and services & software. The reagents segment is expected to account for the largest share and highest CAGR of the market in 2015. • Based on end users, the market is segmented into hospital & academic laboratories, reference laboratories, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). As most diagnostic tests are carried out in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories, owing to which the reference laboratories segment is poised to grow at the highest CAGR during the forecast period. http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

  4. Market Segmentation • This market study majorly covers the products and services, applications, technologies, and end users for arriving at the overall molecular diagnostics market size in the period from 2015 to 2020. • Molecular Diagnostics Market, by Products and Services • Instruments • Reagents • Services & Software • Molecular Diagnostics Market, by Technology • Polymerase Chain Reaction (PCR) • Isothermal Nucleic Acid Amplification Technology (INAAT) • Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)] • DNA Sequencing and Next-generation Sequencing • Microarrays • Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis) http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

  5. Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMérieux SA (France), and Cepheid Inc. (U.S.). • The major factors driving this market are high prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the market. • Request Knowledge Store Demo : • http://www.marketsandmarkets.com/Knowledgestore.asp http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

  6. Contact Us Mr. RohanMarkets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, IndiaEmail: sales@marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

  7. About MarketsandMarkets MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

More Related